Question 1

Who are the top researchers at Romark (United States)?

Accepted Answer

Ranked on the quality score, Jean François Rossignol, Jean‐François Rossignol and Matthew C. Bardin lead among researchers whose main affiliation is Romark (United States).

Question 2

What are the most cited papers from Romark (United States)?

Accepted Answer

The most cited paper from Romark (United States) is "Nitazoxanide: A first-in-class broad-spectrum antiviral agent" (Jean‐François Rossignol, 2014), with 578 citations. Next come "Treatment of Diarrhea Caused by Cryptosporidium parvum: A Prospective Randomized, Double‐Blind, Placebo‐Controlled Study of Nitazoxanide" (359) and "Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus" (301).

Question 3

Which research topics does Romark (United States) publish most on?

Accepted Answer

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, interferon and immune responses and Lipid Membrane Structure and Behavior.

Question 4

Which keywords describe research at Romark (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Immune Response, Pathogenesis, Treatment, Vaccine, Antiviral Therapy, Liver Disease and Zoonotic Transmission.

Question 5

Which fields of science does Romark (United States) work in?

Accepted Answer

In all years, 57% of research at Romark (United States) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (54%), Immunology and Microbiology (14%), Chemistry (11%). It does 2.0× the world's share of Health Sciences.

Question 6

Is Romark (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 50% lower than in 2018-2021.